deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02700048

Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

Sponsor: University of Minnesota

Conditions Hypoglycemia Unawareness Type 1 Diabetes
Interventions Intra-nasal saline intra-nasal naloxone
Updated 13 times since 2017 Last updated: Mar 24, 2023 Started: Jun 30, 2016 Primary completion: Jul 31, 2021 Completion: Jul 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

research grant for the trial was not funded

Other terminated trials from University of Minnesota

See all terminations from University of Minnesota

This PHASE1/PHASE2 trial investigates Hypoglycemia Unawareness and Type 1 Diabetes and is currently terminated or withdrawn. University of Minnesota leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Nov 2019 · 12 months · monthly snapshot~Nov 2019 – ~Feb 2020 · 3 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshot~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Apr 2023 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Sep 2022 — Apr 2023 [monthly]

    Terminated PHASE1_PHASE2

  5. Sep 2021 — Sep 2022 [monthly]

    Terminated PHASE1_PHASE2

    Status: Active Not Recruiting → Terminated

▶ Show 8 earlier versions

  1. Feb 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Feb 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Nov 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Nov 2018 — Nov 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  6. Jun 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  7. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Minnesota
Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations